Mediators of Inflammation / 2020 / Article / Tab 2

Research Article

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 2

Laboratory findings of white cell subpopulations in patients with diabetes or not infected with COVID-19.

VariablesNDM ()T2D () value
(×109/L)Normal rangeMedianIncreased no. (%)Decreased no. (%)MedianIncreased no. (%)Decreased no. (%)

WBC3.5-9.54.740 (0.0%)5 (15.2%)6.056 (16.2%)2 (5.4%)
NEU1.8-6.32.501 (3.0%)2 (6.1%)4. 1010 (27.0%)0 (0.0%)
LYM1.1-3.21.430 (0.0%)17 (39.5%)0.983 (8.1%)18 (48.7%)0.097
ESO0.02-0.520.080 (0.0%)8 (24.3%)0.020 (0.0%)16 (43.2%)
BAS0-0.060.022 (6.1%)0 (0.0%)0.031 (2.7%)0 (0.0%)0.960
MON0.1-0.60.457 (21.2%)0 (0.0%)0.5211 (29.7%)0 (0.0%)0.264

1WBC: white blood cell count; NEU: neutrophil count; LYM: lymphocyte count; ESO: eosinophil count; BAS: basophil count; MON: monocyte count. 2Note that the values were calculated by comparisons of absolute values (medians or means) in this table.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.